Status:
COMPLETED
COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients
Lead Sponsor:
Centre Hospitalier de Cornouaille
Collaborating Sponsors:
Centre Hospitalier Régional et Universitaire de Brest
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is a severe disease with poor prognosis in patients receiving in-center haemodialysis (HD). A population-based registry of \>4,000 patients with a diagnosis of COVID-19 receiving kidney repla...
Detailed Description
Hemodialysis patients were excluded from COVID19 vaccine response studies: seroprotection rate? Long-term protection? Different regimens to offer to hemodialysis patients?
Eligibility Criteria
Inclusion
- all in-center haemodialysis individuals eligible and voluntary to receive one of the approved COVID-19 vaccines.
Exclusion
- individuals under 18 years of age
Key Trial Info
Start Date :
January 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04728828
Start Date
January 25 2021
End Date
August 15 2023
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Quimper
Quimper, France, 29000